| Mrs Deborah Lynn Magnin, RN | |
|
37 Junior Ave, Bellmawr, NJ 08031-2117 | |
| (609) 828-6019 | |
| (856) 931-5715 |
| Full Name | Mrs Deborah Lynn Magnin |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - General Practice |
| Location | 37 Junior Ave, Bellmawr, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346471307 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Deborah Lynn Magnin, RN 37 Junior Ave, Bellmawr, NJ 08031-2117 Ph: (609) 828-6019 | Mrs Deborah Lynn Magnin, RN 37 Junior Ave, Bellmawr, NJ 08031-2117 Ph: (609) 828-6019 |
News Archive
Strokes, which occur when the blood supply to part of our brain is interrupted or reduced, are the leading cause of death and disability in the adult population.
A new study has found that people of Hispanic, black and other U.S. ethnic groups have a 10 to 60 percent greater risk of being diagnosed with advanced colorectal cancer, and a 20 to 30 percent higher risk of dying from the disease compared to non-Hispanic whites.
The ongoing wars in Iraq and Afghanistan have resulted in uniquely destructive patterns of combat injuries, including limb-threatening injuries to the knee. In the March special issue of Techniques in Knee Surgery military surgeons serving in Operation Iraqi Freedom and Operation Enduring Freedom share their experience with managing these high-energy injuries of the knee. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.
Hepatitis C is a serious disease, but the biggest threat to someone's health is not the virus itself. Rather, it is the diseases that can result from it such as reduced liver functioning, scar tissue in the liver and potentially cirrhosis.
An analysis conducted by the Finnish Breast Cancer Group and published in The Lancet Oncology shows women at intermediate to high-risk of early breast cancer recurrence who received capecitabine as part of their chemotherapy regimen had a 34% reduction in the risk of the disease returning or death, compared with those taking the chemotherapy combination regimen without capecitabine.
› Verified 2 days ago
Ms. Eileen Theresa Armstrong, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 206 Bergen Ave, Bellmawr, NJ 08031 Phone: 570-351-2093 |